Lawrence A. Kenyon
Listed on 2 Form D filings across 1+ issuer
· Executive Officer
Associated issuers
- Outlook Therapeutics, Inc. CIK 1649989 · NJ
Filings (2)
-
Outlook Therapeutics, Inc.D · May 7, 2026 · NJ · Biotechnology$5MView filing →
-
Outlook Therapeutics, Inc.D · Jan 27, 2025 · NJ · Biotechnology$32MView filing →